NASDAQ:ALLO | Operating Income | Allogene Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$46.92M
2026-03-31-$46.09M
2025-12-31-$42.4M
2025-09-30-$44.9M
2025-06-30-$56.82M
2025-03-31-$65.19M
2024-12-31-$60.49M
2024-09-30-$71.77M
2024-06-30-$71.43M
2024-03-31-$69.5M
2023-12-31-$85.11M
2023-09-30-$63M
2023-06-30-$80.54M
2023-03-31-$99.09M
2022-12-31-$96.4M
2022-09-30-$82.49M
2022-06-30-$76.59M
2022-03-31-$79.99M
2021-12-31$1.71M
2021-09-30-$77.67M
2021-06-30-$71.03M
2021-03-31-$33.2M
2020-12-31-$69.36M
2020-09-30-$68.04M
2020-06-30-$63.16M
2020-03-31-$57.68M
2019-12-31-$64.58M
2019-09-30-$55.01M
2019-06-30-$45.96M
2019-03-31-$36.46M
2018-12-31-$33.05M
2018-09-30-$22.19M
2018-06-30-$135.01M
2018-03-31-$2.6M

Annual Operating Income

DateOperating Income
2025-12-31-$209.32M
2024-12-31-$273.2M
2023-12-31-$327.74M
2022-12-31-$335.54M
2021-12-31-$180.19M
2020-12-31-$258.24M
2019-12-31-$202.01M
2018-12-31-$192.84M